Ergebnis der Suchanfrage nach celle
Inhalte
- Kategorie:
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- Ein Dokumentmehr
- 3
GEA and Believer Meats join forces to scale up cultivated meat production
Ein Dokumentmehr - 2
Record financing rounds at the Munich biotech hub
Ein Dokumentmehr Press release: Alvotech and STADA add to strategic alliance through denosumab partnership
Alvotech and STADA add to strategic alliance through denosumab partnership - STADA assumes marketing license for Alvotech’s proposed biosimilar referencing Prolia®/Xgeva® (denosumab) in Europe, including Switzerland and the UK, as well as rights in selected markets in Central Asia and the Middle ...
Ein DokumentmehrPress release: STADA welcomes CHMP positive opinion on extending indication for Kinpeygo
STADA welcomes CHMP positive opinion on extending indication for Kinpeygo - The CHMP adopted a positive opinion recommending a change to the terms of the marketing authorization of Kinpeygo for the treatment of adults with primary immunoglobulin A, now covering patients with a UPCR of ≥0.8 g/g - ...
Ein Dokumentmehr- 3
GEA begins construction of technology center for alternative proteins in the USA
Ein Dokumentmehr - 4
Technological milestone in the new food industry: GEA presents perfusion as key process at Anuga FoodTec
Ein Dokumentmehr - 9
Football fans from Europe visit the champion of structural change in Gelsenkirchen
Ein Dokumentmehr - 4
GEA at the Anuga FoodTec trade show: Sustainability innovations bolster food industry resilience
Ein Dokumentmehr - 3
GEA invests EUR 18 million in technology center for alternative proteins in the USA
Ein Dokumentmehr - 2
PM: DHL Group mit Wasserstoff-LKWs im Rheinland unterwegs / PR: DHL Group deploying hydrogen trucks in Germany
2 Dokumentemehr Strengthening the Direct Sales and Service System for Business Expansion in Italy
Ein DokumentmehrPress release: STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara
STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara - Marketing authorization issued in European Economic Area for Uzpruvo®, the first biosimilar to Stelara®, a biologic therapy within ...
Ein DokumentmehrTrade Fair Innovation: Universal 3D Printing Software
Ein Dokumentmehr- 5
Reflecting on a successful Pharma Forum 2023
Ein Dokumentmehr The future of road freight transport is electric
Press release Freiburg/Berlin, 29 August 2023 The future of road freight transport is electric The availability of a broad-scale and well-performing charging network by 2035 offers potential to increase new registrations of battery electric trucks to 100 per cent. The key entry point for ensuring the market success of zero-emission drive technologies is ...
Ein Dokumentmehr- 2
Press release: STADA's excellent results in H1 2023 indicate a record annual profit of €1 bn, driven by Consumer Healthcare and Specialty
Ein Dokumentmehr LAMILUX Composites: Lightweights for dry freight trailers
Ein DokumentmehrLAMILUX produces high-tech composites for the bus industry
Ein DokumentmehrLAMILUX Composites protect packages and vehicles
Ein DokumentmehrLAMILUX Composites: Professional material for food transport
Ein Dokumentmehr- 4
Shaping the sustainable fibre future with cellulose fibres – Abstract submissions open for the Cellulose Fibres Conference 2024
Ein Dokumentmehr LAMILUX Composites Establishment of the new division "Business Unit Building and Construction"
Ein Dokumentmehr- 2
Brand new: Six new online presentations on GRP
Ein Dokumentmehr LAMILUX Composites at Caravan Salon 2023, Hall 13 Stand A85
Ein DokumentmehrLAMILUX Composites joins the Bavarian Environmental and Climate Pact
Ein Dokumentmehr- 2
LAMILUX SUNSATION® wins German Innovation Award
Ein Dokumentmehr - 3
PR: LAMILUX Composites innovations at transport logistic
Ein Dokumentmehr - 4
The rise of Carbon Dioxide (CO₂) as a renewable carbon feedstock – More than 1.3 million tonnes capacity for CO₂-based products already exist and are expected to at least quadruple by 2030
Ein Dokumentmehr Press release: STADA and Xbrane launch ranibizumab to support patient access in Europe
STADA and Xbrane launch ranibizumab to support patient access in Europe - Ranibizumab biosimilar is being launched in major European markets - Ranibizumab is the first product brought to market through a strategic collaboration between STADA and Xbrane, marking Xbrane’s first commercial launch and ...
Ein Dokumentmehr